==== Front J Fungi (Basel) J Fungi (Basel) jof Journal of Fungi 2309-608X MDPI 33238603 10.3390/jof6040310 jof-06-00310 Review Epidemiology and Diagnostic Perspectives of Dermatophytoses https://orcid.org/0000-0001-7136-3990Petrucelli Monise Fazolin 1 de Abreu Mariana Heinzen 1 Cantelli Bruna Aline Michelotto 1 Segura Gabriela Gonzalez 1 Nishimura Felipe Garcia 1 Bitencourt Tamires Aparecida 123 https://orcid.org/0000-0001-7389-4023Marins Mozart 1 https://orcid.org/0000-0001-8755-9250Fachin Ana Lúcia 1* 1 Biotechnology Unit, Unaerp, Av. Costábile Romano, 2201, Ribeirão Preto SP 14096-900, Brazil; mofazolin@gmail.com (M.F.P.); mariheinzen@gmail.com (M.H.d.A.); brucantelli@hotmail.com (B.A.M.C.); gabrielagonzalezsegura@hotmail.com (G.G.S.); felipegnishi@hotmail.com (F.G.N.); tabitencourt@yahoo.com.br (T.A.B.); mmarins@gmb.bio.br (M.M.) 2 Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto SP 14049-900, Brazil 3 Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto SP 14049-900, Brazil * Correspondence: afachin@unaerp.br; Fax: +55-16-3603-7030 23 11 2020 12 2020 6 4 31015 10 2020 02 11 2020 © 2020 by the authors.2020Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).Dermatophytoses affect about 25% of the world population, and the filamentous fungus Trichophyton rubrum is the main causative agent of this group of diseases. Dermatomycoses are caused by pathogenic fungi that generally trigger superficial infections and that feed on keratinized substrates such as skin, hair, and nails. However, there are an increasing number of reports describing dermatophytes that invade deep layers such as the dermis and hypodermis and that can cause deep infections in diabetic and immunocompromised patients, as well as in individuals with immunodeficiency. Despite the high incidence and importance of dermatophytes in clinical mycology, the diagnosis of this type of infection is not always accurate. The conventional methods most commonly used for mycological diagnosis are based on the identification of microbiological and biochemical features. However, in view of the limitations of these conventional methods, molecular diagnostic techniques are increasingly being used because of their higher sensitivity, specificity and rapidity and have become more accessible. The most widely used molecular techniques are conventional PCR, quantitative PCR, multiplex PCR, nested, PCR, PCR-RFLP, and PCR-ELISA. Another promising technique for the identification of microorganisms is the analysis of protein profiles by MALDI-TOF MS. Molecular techniques are promising but it is necessary to improve the quality and availability of the information in genomic and proteomic databases in order to streamline the use of bioinformatics in the identification of dermatophytes of clinical interest. deep infectionsMALDI-TOF MSmycological diagnosisPCRTrichophyton rubrum ==== Body 1. Epidemiology of Infections Caused by Dermatophytes Dermatophytoses are mycoses caused by pathogenic fungi that generally trigger superficial infections in animals and particularly in humans. These dermatophytoses are mainly caused by filamentous fungi that can invade and feed on keratinized substrates [1] such as skin, hair, and nails [2]. The group of dermatophytes comprises 52 keratin-degrading species divided into nine genera: Trichophyton, Microsporum, Epidermophyton, Arthroderma, Lopophyton, Nannizia, Ctenomyces, Guarromyces, and Paraphyton [3]. Among the fungi causing dermatophytoses in humans, the filamentous fungus Trichophyton rubrum is the main causative agent of cutaneous infections of the feet, nails, and body [4]. Infections caused by dermatophytes are called “tineas” and are classified according to the affected site, as shown in Table 1. Infections of the scalp, called tinea capitis, are more common in children, while other tineas more commonly affect postpubertal individuals. The hormonal changes that occur after puberty induce the secretion of acids by sebaceous glands, which, in turn, reduce the incidence of tinea capitis but not of other mycoses. Onychomycoses prevalence increases with, for instance, age. [5] Dermatophytoses affect individuals worldwide but their incidence is higher in tropical countries because of high temperatures and humidity [12]. Factors that influence the development of dermatophytoses include age, sex, season of year, socioeconomic and cultural conditions, and geographic location [13]. It is estimated that about 10 to 15% of individuals are contaminated with dermatophytes at some point in their life [14]. According to data from the World Health Organization (WHO), dermatophytoses affect about 25% of the world population [15] and 30 to 70% of adults are asymptomatic carriers of these diseases. In Western countries, 80 to 90% of onychomycosis cases are primarily caused by dermatophytes, with 5–17% being due to yeasts and 2–3% to non-dermatophyte molds. In southern European countries, dermatophytes are the causative agents of 40 to 68% of cases, with 21–55% being due to yeasts. In Asian and Middle Eastern countries, dermatophytes account for 40 to 48% of cases, with 43–46% of infections being caused by yeasts and 8–11% by non-dermatophyte molds. Comparatively, in Africa, onychomycosis-related infections are predominantly caused by yeasts [16]. The high prevalence of nail infections in North America is largely due to immigration of dermatophytes from other regions of the world such as West Africa and Southeast Asia. The global prevalence of tinea pedis is estimated at 5.5%, accounting for 50% of all cases of nail disease [17]. Among fungal infections that affect the nails, almost 50% are caused by dermatophytes [18]. It is estimated that tinea pedis is present in 30–70% of the world population. The condition is caused mainly by T. rubrum, T. mentagrophytes var. interdigitale and Epidermophyton floccosum, and men are more affected than women [19]. The main causative agent of tinea corporis is T. rubrum, which is responsible for 80 to 90% of infections. This prevalence is even higher in men and in children younger than 15 years [20,21]. The risk of onychomycosis increases with age, probably due to the presence of diabetes, poor peripheral circulation, longer exposure to pathogenic fungi, repeated nail trauma, and suboptimal immune function. A family history of onychomycosis is another risk factor [16]. Trichophyton rubrum and E. floccosum are dermatophytes found worldwide, with T. rubrum being the most common species [22]. In addition, other dermatophytes are found in specific regions such as Microsporum ferrugineum in Asia, T. megninii in Europe, and T. concentricum in South America. Despite the specificity of these species in each region, T. rubrum continues to be the main causative agent, except for Africa where a variety of dermatophytes exist in each microregion, with Microsporum audouinii and T. soudanense being the most common species [4,23,24]. It is common to find in the literature several articles with epidemiological data from tropical regions. In Brazil, epidemiological data show a higher incidence of infections caused by T. rubrum in the southern and southeastern regions, followed by M. canis and T. mentagrophytes. On the other hand, a higher prevalence of T. tonsurans, T. rubrum, and M. canis is observed in the northeastern region [25,26,27]. Another example are countries on the African continent, where particularly Ethiopia, has a high number of cases of dermatophytosis, not only due to the climatic factor, but also because it is a country with low socioeconomic status, low level of hygiene and health care, and overcrowding [28,29,30]). India is also a country from which several articles are published, and which goes through the same problems as Ethiopia [31,32,33]. 2. Deep Infection Caused by Dermatophytes Dermatophytes generally cause superficial infections; however, there are an increasing number of reports describing dermatophytes that invade deep layers such as the dermis and hypodermis and that can spread to the lymph nodes, brain, and bloodstream, causing deep infections [34]. Some conditions are necessary for the establishment of this infection in the patient, including an immunosuppressive state, obesity, diabetes, and advanced age, in addition to other health problems [35]. Other factors related to this disease are environmental factors and a genetic predisposition [36]. Table 2 describes cases of deep infections caused by dermatophytes, highlighting the importance of the correct diagnosis and treatment of these infections. 3. CARD 9 Mutation and Fungal Infections One protein that has attracted attention in invasive infections is CARD9 because of the correlation between mutations in this protein and severe infections caused by dermatophytes [45]. CARD9 is a signaling protein with a caspase recruitment domain that plays a key role in the innate and adaptive immunity. The CARD9 adapter has been shown to enable pattern recognition receptors to induce NF-κB and MAPK activation, an event that triggers a cascade of inflammatory cytokines and provides effective protection against microbial invasion, especially fungal infection [46]. Furthermore, [47] described the case of an individual with skin lesions and localized dermatitis on the neck and face. A skin biopsy revealed the presence of septate and pigmented hyphae characteristic of Phaeohyphomycosis. DNA was extracted from the patient because of the absence of a history of comorbidities and CARD9 deficiency was detected. 4. Diagnostic and Identification Methods for Dermatophytoses: from Conventional to Molecular Methods Diagnosis relies on the culture (positive or negative) and microscopy (distinct direct microscopy and histology, positive or negative as well). Cultures can then be identified using microscopy, MALDI-TOF MS or DNA sequencing. Molecular assays based on DNA (PCR) can provide both diagnosis and identification directly from clinical samples, depending on the assay. 4.1. Culture, Microscopy, Histology and Molecular Assays Based on DNA The conventional methods most commonly used in mycology laboratories for the diagnosis of keratinophilic fungi are based on colony characteristics, microscopic morphology [48], growth requirements, and the results of physiological and biochemical tests. Morphological parameters are the colony pattern, pigmentation, and growth rate. Physiological tests evaluate the hydrolysis of urea and in vitro hair perforation capacity of the fungus. Biochemical parameters include the assimilation of sorbitol [49]. The analysis of physiological and biochemical parameters is useful to distinguish T. rubrum from T. mentagrophytes, as described by [49]. The conventional identification and diagnosis of dermatophytosis involves techniques of culture and morphological identification of the fungus or the detection of fungal elements by direct microscopy of clinical specimens. Sabouraud dextrose agar or potato dextrose agar is used for the isolation and identification of dermatophytes based in macroscopic characteristics such as colony color and surface. The medium is supplemented with antibiotics and cycloheximide, a reagent specific for the selection of this group of fungi. [17,48,50]. Direct microscopy can be used as a low-cost, rapid result, and an easy-to-do office diagnostic test. However, this test lacks sensitivity and can be enhanced with the combination with histology testing, using periodic acid-Schiff (PAS), for example [17]. The isolation followed by identification by direct microscopic or histology of dermatophytes was considered as a gold standard method. However, this method is limited depending on the quality of the collected sample. For correct isolation of the infectious agent, asepsis of the lesion with 70% alcohol is necessary to eliminate other contaminants, as well as adequate techniques for collection of the affected tissue [48,51]. Consequently, the false-negative rate of this diagnostic method is high, about 35%. In addition, it does not permit to determine the causative fungal species and its viability [17]. In the case of dermatophytes, morphological similarity and the limited or absent sporulation of some species hinder identification by these conventional methods. In addition to these factors, the culture of these species for diagnosis is a time-consuming process, with the growth of some fungi taking up to 6 weeks, delaying the identification of the causative species and the initiation of appropriate therapy [48]. In dermatophytoses, the isolation and correct identification of the causative agent are essential for the choice of adequate treatment. For example, infections caused by anthropophilic dermatophytes require shorter treatment than those caused by zoophilic dermatophyte species. On the other hand, non-dermatophyte fungal species may not respond adequately to the treatment used for dermatophytoses [48]. Some non-dermatophyte species such as Fusarium, Acremonium, and Aspergillus were identified as causative agents of onychomycoses in patients who did not respond to treatment with terbinafine or itraconazole [52]. These antifungal agents have been well established for the treatment of onychomycoses caused by dermatophytes. The wrong diagnosis or lack of identification of the causative agent in these patients may have led to the incorrect hypothesis of the existence of resistant dermatophyte strains in these cases [48]. Thus, the correct identification of the causative fungal species will help to more accurately determine the appropriate treatment, reducing cases of recurrent infections, in addition to contributing to the investigation and control of epidemics [17,48]. Considering the limitations of conventional methods for the identification and diagnosis of dermatophytes, molecular diagnostic techniques are increasingly being used because of their higher sensitivity and specificity and the shorter time necessary for identification of the causative agent. In addition, these methods have become more accessible. Molecular assays based on DNA can provide both diagnosis and identification of the infectious agent directly from clinical samples. Rapid and accurate identification of dermatophytes is essential for the successful treatment of patients with these infections [48]. Molecular diagnostic methods involve the extraction of DNA from the fungus present in clinical samples. The genetic material can be extracted by the traditional phenol-chloroform method or with commercial DNA extraction kits, which provide more efficient extraction. The presence of keratin in clinical sample requires digestion of this protein by enzymatic or non-enzymatic methods [48,53]. DNA extraction followed by the application of different methods for molecular diagnosis has advanced significantly in the last 15 years [48]. DNA sequences are very useful for this purpose and permit an accurate identification. The internal transcribed spacer polymorphisms ITS1 and ITS2 that flank the region encoding the 5.8S rDNA show adequate and reliable sensitivity in distinguishing different species. In addition, the 28S rDNA sequences and genes encoding topoisomerase II and chitin synthase I are used for the identification of dermatophyte species [53]. Molecular diagnostic methods that provide good sensitivity and specificity as well as fast results include the polymerase chain reaction (PCR) and real-time PCR techniques. Studies using PCR reported a rate of correct diagnoses of 74–100% [54]. Conventional PCR is the most widely used method as it provides the best cost–benefit ratio, as well as rapid detection. This technique uses primers amplifying DNA sequences that are specific for the species to be identified. Specific primers to detect any dermatophyte species in a sample (pan-dermatophyte primers) or primers that detect any fungal species (pan-fungal primers) can also be used [53]. The results are interpreted by analyzing the size of the amplicons generated on agarose gel [48,53]. In the study of [55] comparing the performance of different methods for the diagnosis of onychomycosis in 60 patients, the best sensitivity (> 90%) was observed for PCR. In a similar study, [56] suggested the use of PCR as a complementary method for clinical confirmation of suspected cases of onychomycosis. In addition, [57] observed that PCR reduced the time necessary for the diagnosis of dermatophytosis from 4 weeks to 7 h when conventional culture growth was compared with the molecular method, confirming the rapidity and efficacy of PCR. A post-test called nested PCR can also be used to increase the sensitivity in dermatophyte detection during the diagnosis by conventional PCR [48,57]. This test is a modification of the conventional PCR technique and consists of a second amplification of the fragment amplified by conventional PCR. In this method, the fragment amplified in the first PCR is used as a template for the second amplification, employing primers that only flank the region of the fragment amplified in the first reaction. The aim of this post-PCR technique is to reduce the nonspecific binding of products generated in the first PCR, increasing specificity and sensitivity [48]. Using pan-dermatophyte primers, [58] performed nested PCR for the amplification of translation elongation factor 1-α (Tef-1α) in order to increase the accuracy of identification of relevant dermatophytes in samples of animals with dermatophytosis. Although they increase the sensitivity of conventional PCR, the disadvantage associated with post-PCR techniques is the high risk of contamination of the already amplified PCR products due to the manipulation of these fragments in nested PCR, in addition to prolonging the time to diagnosis [48,53]. Another variant of the PCR technique called multiplex PCR allows the identification of multiple targets in a single reaction, with the benefit of saving time and speeding up the diagnosis. However, for the success of multiplex PCR, it is important to evaluate the possibility of dimerization between the primers used in order to prevent nonspecific amplification. This variant of conventional PCR increases the efficiency of detection and reduces the risk of false-negative results. Highlighted the efficiency, sensitivity, and specificity of multiplex PCR for a faster diagnosis of onychomycosis caused by dermatophytes and by Fusarium spp [59]. Similarly, recommended the use of multiplex PCR for the diagnosis of dermatophytic onychomycosis in cases with a negative culture or when the culture is contaminated with fast-growing fungi, a fact that renders the identification of the causal agent problematic [60]. The combination of the restriction fragment length polymorphism (RFLP) technique and PCR can also be used for the identification and discrimination of fungal species in dermatological samples. The so-called PCR-RFLP technique consists of the amplification of specific nucleic acid fragments that exhibit small genetic variations, followed by restriction enzyme analysis and identification of the fragments by gel electrophoresis [48]. This technique can also be used to investigate the composition of microbial communities in different ecological systems such as water and soil [53]. Studying 35 patients with a suspicion of onychomycosis [61] obtained 85.71% sensitivity using PCR-RFLP as the diagnostic test, suggesting that this method is more accurate in the diagnosis of onychomycosis than conventional culture. Used PCR-RFLP to evaluate inter- and intraspecific genomic variations among clinically important dermatophytes isolated from clinical samples [62]. The advantages of PCR-RFLP include its low cost and easy design, as well as the fact that no sophisticated equipment is required. However, it is a laborious technique that involves the use of restriction enzymes and identification and knowledge of the desired genetic variants, requiring more time for analysis. Thus, PCR-RFLP is generally not used for routine diagnostics [48]. An alternative assay with a higher diagnostic sensitivity than analysis by gel electrophoresis [53] is PCR-enzyme-linked immunosorbent assay (ELISA). This is a hybrid technique of PCR and ELISA; however, instead of detecting proteins as in a traditional ELISA, PCR-ELISA permits the direct detection of nucleic acids amplified by PCR [48]. This method was developed to increase the sensitivity of detection of dermatophytes in infected tissues and nails. For diagnosis, a PCR amplification with digoxygenin is first performed, generating PCR products labeled with digoxigenin that bind to biotin-labeled oligonucleotides. The biotinylated PCR products are immobilized on a microplate and are detected with anti-digoxigenin. Alternatively, hybridization of the PCR products to fluorescein-labeled oligonucleotide probes can also be performed, followed by detection with horseradish peroxidase-conjugated anti-fluorescein antibodies [48,53]. PCR-ELISA with amplification of the topoisomerase II gene and detection by hybridization using digoxigenin-labeled probes resulted in the successful identification of dermatophyte species such as T. rubrum, T. interdigitale, T. violaceum, M. canis, and E. floccosum directly in clinical samples within 24 h [53,63]. Dermatophytes of the genus Trichophyton were also successfully identified by PCR-ELISA in epidemiological studies conducted in India using skin scrapings from 201 patients [64]. A commercial kit for the detection of dermatophytes in cases of onychomycosis, called Onychodiag, was developed based on the PCR-ELISA technique. However, this technique is not used as a routine laboratory test because of the need for elaborate manipulations and the longer time to diagnosis [48,53]. A very promising method to minimize the risks of contamination and to eliminate the need for post-PCR tests and gel electrophoresis analysis of the results is real-time PCR. This method is also used for the diagnosis of dermatophytosis [48,53]. Real-time PCR detects the presence of DNA or RNA, thus enabling the rapid identification especially of microorganisms. In addition to detecting infectious agents, this technique also provides quantitative data regarding the number of microorganisms present in the sample. Analysis of the results is based on the threshold cycle value (Ct), which corresponds to the number of PCR amplification cycles at which the fluorescence generated within a reaction crosses the fluorescence threshold. Thus, the higher the amount of genetic material present in the sample, the smaller the number of cycles necessary for a positive result and the greater the emitted fluorescence; consequently, low Ct values will be obtained [65]. The diagnostic results obtained by real-time PCR are usually reported as positive, negative, or indeterminate [65]. The quantitative nature of the method in estimating the fungal load of a sample, for example, helps with the differentiation between infection and contamination of clinical samples based on the threshold values obtained in cases of infection. Within this context, studies suggest that real-time PCR can be applied successfully for the diagnosis of dermatophytosis with much higher precision compared to classical diagnostic methods [48]. Furthermore, evaluating dermatophytes in nail samples, [66] showed that real-time PCR detected the presence of dermatophytes in samples that tested negative by conventional PCR, suggesting a higher diagnostic sensitivity of the former. In an attempt to increase the diagnostic response, real-time PCR can be performed as described by [67], who indicates multiplex RT-PCR as the fastest and most efficient method for the identification of dermatophyte species in clinical samples, or using pan-dermatophyte primers as described by [66] for the diagnosis of dermatophytes in nail samples. Commercial kits designed to facilitate the identification of dermatophytes by real-time PCR have also been developed. One example is the Derma Genius® multiplex kit for the accurate and rapid identification of T. rubrum, T. interdigitale, and Candida albicans in nails [68]. Taken together, it is evident that the development of molecular techniques has brought several benefits, permitting a better diagnosis of dermatophytoses and more appropriate treatment for patients with these diseases. 4.2. MALDI-TOF-MS Another promising technique for the identification of microorganisms is the fingerprint of a protein extract by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). This method is applied to the identification of a wide range of species [69,70,71,72,73,74], including dermatophytes [69,70,71,72,73,74,75,76,77,78] but until now, is not used in clinical diagnostic method for dermatophytosis. In addition, this approach has drastically reduced the response times in routine clinical laboratories [72,74,77,79]. MALDI-TOF MS uses the characteristic fingerprint of a protein to identify a specific microorganism by combining species–specific protein patterns included in a comprehensive reference spectra library [80]. Hence, the identity of microorganisms can be established at the species level in mycology [75,81]. In the case of fungi in general, identification by MALDI-TOF MS can be compromised if the sample is contaminated with culture medium, especially when fungal colonies are present and cannot be separated from the agar [79]. This limitation is also discussed by [82], which suggested the use of a new medium called Id-Fungi plates (IDFP) from Conidia®. The use of this technique for the study of dermatophytes is more complex because of the variable phenotypes of these fungi, which can result in variations of the protein spectra; this heterogeneity is affected by the growth conditions and by the mycelial zone examined (concomitant presence of different fungal structures, hyphae and/or conidia, in the same culture) [83,84]. However, the main limitation for the identification of dermatophytes is the inadequate representation of dermatophyte species in the reference spectra libraries of the current commercial MALDI-TOF MS identification systems. Identification by MALDI-TOF MS still requires the successful growth of fungus in culture. However, even in the case of adequate sampling, dermatophytes exhibit relative low sensitivity, with approximately 30% of the culture results being false negative [85,86]. The main concern associated with the identification of pathogenic fungi by MALDI-TOF MS are the similarities of molecular components, which can render sister species indistinguishable, for example, Trichophyton rubrum and T. violaceum or Microsporum canis and M. audouinii [70,71,78,87]. For each MALDI-TOF MS system, the reference database for species coverage is essential for the approach, as long as the database used in the analysis of MALDI-TOF MS is improved to include adequate spectra of different strains of each species studied [88]. Within this context, laboratories are recommended to generate and complement the mass spectra for their main local species or lineages and to register them with commercial reference libraries [89]. In contrast to bacteria, fungi require additional processing steps to break the cell wall, extract proteins, and inactivate the isolate [90]. These additional processing steps and limited libraries have led laboratories to develop their own methodologies and databases in an attempt to overcome the barriers to the adoption of the technique [70,74,91]. The time, media and culture conditions used for the strain to be identified must be the same as those used as a reference in the database used for comparison and spectral identification so that there are no changes in the microorganism protein profiles [70,92]. These limitations have prevented the widespread implementation of this technology in clinical laboratories for the identification of filamentous fungi. Another limitation of MALDI-TOF MS is that, unlike publicly available sequence databases such as GenBank, commercial MALDI-TOF MS databases are usually exclusive to companies. Although the low identification rates for some organisms may be increased by user addition of mass spectral entries of under-represented species or strains (to cover intraspecies variability), or even by the re-addition of reference strain spectra to the library, especially those created using parallel growth conditions and preparation methods, doing so may be beyond the capacity of some laboratories [93]. A non-commercial option is available through an online identification tool that comprises more than 900 species of fungi and more than 200 genera of fungi, which allows the identification of fungi, including dermatophytes, for free thus facilitating the identification of fungi [94]. Four different commercial MALDI-TOF MS platforms for the routine identification of fungi in clinical microbiology laboratories are currently available. These platforms include the Andromas (Andromas SAS, Paris, France), Axima@ Saramis (Shimadzu/AnagnosTec, Duisburg, Germany), Bruker Biotyper (Bruker Daltonics, Bremen, Germany), and Vitek MS (bioMérieux, Marcy l’Etoile, France) systems [95]. The reported identification rates of dermatophytes by MALDI-TOF MS range from 13.5% to 100% [79]. However, the efficiency of this technique depends primarily on the standard library provided by the manufacturer or a supplementary library of the manufacturer. The use of these standard libraries supports the reported variable findings, for example, expansion of the library improves the accuracy of identification of dermatophytes by MALDI-TOF MS [70,78,79]. Effective identification of dermatophyte species depends on the number and variety of isolates available in the reference spectral library [70,72,78,79]. Table 3 summarizes the main advantages and disadvantages of each method for the identification and diagnosis of the dermatophytes discussed in this article. 5. The Potential of Molecular Approaches for the Study of Dermatophytes A vast range of molecular approaches exist in clinical mycology. These approaches are not only limited to diagnostic tests but can also be used for prospecting new antifungal compounds for the treatment of these diseases, as done by [97,98,99], as well as for the identification of conserved regions that contribute to the virulence of these pathogens as described by [100], enabling the discovery of new therapeutic targets. Moreover, technologies for large-scale transcriptome analyses such as RNAseq and microarray have contributed to a better understanding of dermatophyte-host interactions at the molecular level [101,102], in addition to providing new insight into the effect of commercial antifungals such as terbinafine on species such as T. rubrum. Modulation of 277 differentially expressed genes was observed in co-cultures of the dermatophyte T. rubrum with the HaCat keratinocyte cell line in the presence of terbinafine. Approximately 28% of these genes have been studied in other dermatophytes but not in T. rubrum, thus contributing to the elucidation of the functions of these genes in this species and of the response mechanisms to antifungal agents. In addition, modulation of different genes with an important role in the biosynthesis and transport of ergosterol, such as ERG1, ERG5, ERG11, CYP51, and CYP61, was demonstrated [103]. 6. Future Perspectives Major advances have been made over the years in the identification and diagnosis of dermatophytes. However, some limitations, such as the lack of a complete database for the identification of pathogenic fungi, are still an obstacle. The establishment of an extensive online database containing the molecular profiles of fungal species involved in human diseases, with the possibility of inclusion of additional information by users, would be a major advance in this field. This requires the development of reliable algorithms that allow the rapid consultation of thousands of reference molecular profiles and easy access for everyone. Acknowledgments We thank S.C. França and the staff of the Biotechnology Unit-UNAERP for general support. Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Author Contributions Conceptualization, M.F.P., M.H.d.A. and A.L.F.; writing—original draft preparation, M.F.P., M.H.d.A. G.G.S., B.A.M.C., F.G.N., T.A.B., A.L.F., M.M. writing—review and editing; M.F.P., M.H.d.A. G.G.S., B.A.M.C., F.G.N., T.A.B., A.L.F., M.M., A.L.F. designed the project, supervised the research, contributed reagents/materials/analysis tools, and wrote the manuscript. All authors have read and agreed to the published version of the manuscript. Funding This study was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, 2019/10514-8) and CAPES (Ph.D. fellowships). Conflicts of Interest The authors declare no conflict of interest. jof-06-00310-t001_Table 1Table 1 Main types of “tineas”. Tinea Main Dermatophyte Site of Infection Reference Tinea corporis Trichophyton rubrum T. tonsurans Microsporum canis Body (chest, face, arms, and/or legs) [6] Tinea pedis (athlete’s foot) T rubrum T. interdigitale Epidermophyton floccosum Foot (soles or interdigital spaces) [7] Tinea capitis T. tonsurans Microsporum canis Trichophyton violaceum Trichophyton soudanense Scalp [8,9] Tinea cruris T. rubrum Groin folds [10] Tinea unguium (onychomycosis) T. rubrum T. interdigitale Nails [11] jof-06-00310-t002_Table 2Table 2 Case reports of deep infections caused by dermatophytes. Comorbidity Symptoms Reference Hepatitis C and liver cirrhosis Subcutaneous nodules [37] Human immunodeficiency virus (HIV) Atypical, multiple or extensive lesions [38] Transplant and chemotherapy patients Nodules [39] History of diabetes mellitus Palpable nodules in the ankle [40] Patients without immunodeficiency, history of onychomycosis Erythema, papules and nodules in the submandibular area, neck, and chest [41] Use of immunosuppressive drugs Fungal abscesses [42] Patients without immunodeficiency, hypertension and angina Red spots with secretion [43] Fungal infection for 2 years, onychomycosis Loss of vision [44] jof-06-00310-t003_Table 3Table 3 Main advantages and disadvantages of the identification and diagnostic methods used for dermatophytes. Methods of Identification/Diagnosis Advantages Disadvantages Reference Conventional (culture followed by direct microscopy or histology) Low cost of materials Well-established standard method Time-consuming process to obtain the result High false-negative rate [48,51,96] Conventional PCR Better cost–benefit ratio Rapid detection Post-PCR tests might be necessary to complement the diagnosis [53] Nested PCR Reduces nonspecific binding of PCR products More specific results Good sensitivity High risk of contamination Prolongs the time to diagnosis [48,53] Multiplex PCR Identification of multiple targets in the same reaction Time saving and rapid diagnosis Higher detection efficacy Reduces the risk of false-negative results Possibility of nonspecific binding between primers [48] PCR-RFLP Low cost Does not require sophisticated equipment Use of restriction enzymes is necessary Requires more time for diagnostic analysis Not commonly used for diagnosis [48] PCR-ELISA Higher sensitivity than techniques that use analysis by gel electrophoresis Elaborate manipulations are necessary Requires more time for diagnostic analysis Not commonly used for diagnosis [48,53] Real-time PCR Low risk of contamination Post-PCR tests are not required Rapid identification Quantitative detection Specific equipment is necessary Higher cost than conventional PCR [48,53,65] MALDI- TOF MS Identification of the microorganism at the genus, species, and strain level Difficulty of access or incomplete information of some dermatophyte species in databases used for identification Sister species might be indistinguishable because of similar molecular components [70,71,72,74,75,77,79,81,85,86,87,93] ==== Refs References 1. Gnat S. Łagowski D. Nowakiewicz A. Zięba P. The host range of dermatophytes, it is at all possible? Phenotypic evaluation of the keratinolytic activity of Trichophyton verrucosum clinical isolates Mycoses 2019 62 274 283 10.1111/myc.12876 30537378 2. Khurana A. Sardana K. Chowdhary A. Antifungal resistance in dermatophytes: Recent trends and therapeutic implications Fungal Genet. Biol. 2019 132 103255 10.1016/j.fgb.2019.103255 31330295 3. Mercer D.K. Stewart C.S. Keratin hydrolysis by dermatophytes Med. Mycol. 2019 57 13 22 10.1093/mmy/myx160 29361043 4. Antuori A. Fernández G. Fernández A. Alcaide M. Boada A. Bielsa M.I. Romaní N. Matas L. Epidemiology of dermatophytic infections between 2008 and 2017 in Barcelona, Spain Enferm. Infecc. Microbiol. Clin. 2019 37 642 647 10.1016/j.eimc.2019.02.010 31076176 5. Bhavsar Hitendra K. Modi Dhara J. Sood Nidhi K. Shah Hetal S. A Study of Superficial Mycoses With Clinical Mycological Profile in Tertiary Care Hospital in Ahmedabad, Gujarat Natl. J. Med. Res. 2012 2 160 164 6. Leung A.K. Lam J.M. Leong K.F. Hon K.L. Tinea corporis: An updated review Drugs Context 2020 9 1 12 10.7573/dic.2020-5-6 7. Woo T.E. Somayaji R. Haber R.M. Parsons L. Diagnosis and Management of Cutaneous Tinea Infections Adv. Skin Wound Care 2019 32 350 357 10.1097/01.ASW.0000569128.44287.67 31335433 8. Grigoryan K.V. Tollefson M.M. Olson M.A. Newman C.C. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States Int. J. Dermatol. 2019 58 912 915 10.1111/ijd.14352 30548845 9. Leung A.K.C. Hon K.L. Leong K.F. Barankin B. Lam J.M. Tinea Capitis: An Updated Review Recent Pat. Inflamm. Allergy Drug Discov. 2020 14 58 68 10.2174/1872213X14666200106145624 31906842 10. Bishnoi A. Mahajan R. Tinea cruris Diagnostics to Pathogenomics of Sexually Transmitted Infections wiley Hoboken, NJ, USA 2018 329 340 9781119380924 11. Asz-Sigall D. Tosti A. Arenas R. Tinea Unguium: Diagnosis and Treatment in Practice Mycopathologia 2017 182 95 100 10.1007/s11046-016-0078-4 27787643 12. Taplin D. Dermatophytosis in Vietnam Cutis 2001 67 19 20 13. Iorio R. Cafarchia C. Capelli G. Fasciocco D. Otranto D. Giangaspero A. Dermatophytoses in cats and humans in central Italy: Epidemiological aspects Mycoses 2007 50 491 495 10.1111/j.1439-0507.2007.01385.x 17944712 14. Pires C.A.A. da Cruz N.F.S. Lobato A.M. de Sousa P.O. Carneiro F.R.O. Mendes A.M.D. Clinical, epidemiological, and therapeutic profile of dermatophytosis An. Bras. Dermatol. 2014 89 259 264 10.1590/abd1806-4841.20142569 24770502 15. Sai B.S. Tejashree A. Veeranna S. Krishna Karthik M. Speciation and In Vitro Activity of Four Antifungal Drugs Against Clinical Isolates of Dermatophytes By E-Test Method Int. J. Sci. Res. 2019 8 10.36106/ijsr 16. Gupta A.K. Stec N. Emerging drugs for the treatment of onychomycosis Expert Opin. Emerg. Drugs 2019 24 213 220 10.1080/14728214.2019.1685493 31652088 17. Gupta A.K. Versteeg S.G. Shear N.H. Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment J. Cutan. Med. Surg. 2017 21 525 539 10.1177/1203475417716362 28639462 18. Rafat Z. Hashemi S.J. Saboor-Yaraghi A.A. Pouragha B. Taheriniya A. Moosavi A. Roohi B. Arjmand R. Moradi A. Daie-Ghazvini R. A systematic review and meta-analysis on the epidemiology, casual agents and demographic characteristics of onychomycosis in Iran J. Mycol. Med. 2019 29 265 272 10.1016/j.mycmed.2019.05.004 31285126 19. Dalla Lana D.F. Batista B.G. Alves S.H. Fuentefria A.M. Dermatofitoses: Agentes etiológicos, formas clínicas, terapêutica e novas perspectivas de tratamento Clin. Biomed. Res. 2016 36 230 241 10.4322/2357-9730.68880 20. Seebacher C. Bouchara J.-P. Mignon B. Updates on the Epidemiology of Dermatophyte Infections Mycopathologia 2008 166 335 352 10.1007/s11046-008-9100-9 18478365 21. Piggott C.D.S. Friedlander S.F. Dermatophytes and Other Superficial Fungi Principles and Practice of Pediatric Infectious Diseases: Fourth Edition Elsevier Inc. Amsterdam, The Netherlands 2012 1246 1250.e2 9781437720594 22. Cordeiro L.V. Perfil Epidemiológico De Dermatofitoses Superficiais Em Pacientes Atendidos Em Um Laboratório Da Rede Privada De João Pessoa-Pb Universidade Federal Da Paraíba João Pessoa, Brazil 2015 23. Hayette M.P. Sacheli R. Dermatophytosis, Trends in Epidemiology and Diagnostic Approach Curr. Fungal Infect. Rep. 2015 9 164 179 10.1007/s12281-015-0231-4 24. Jha B. Bhattarai S. Sapkota J. Sharma M. Bhatt C.P. Dermatophytes in Skin, Nail and Hair among the Patients Attending Out Patient Department J. Nepal Health Res. Counc. 2019 16 434 437 10.33314/jnhrc.v16i41.1651 30739936 25. Teixera N. Peres D.A. Rossi A. Dermatófitos: Interação patógeno-hospedeiro e resistência a antifúngicos An. Bras. Dermatol. 2010 85 657 667 21152790 26. Silva-Rocha W.P. de Azevedo M.F. Chaves G.M. Epidemiology and fungal species distribution of superficial mycoses in Northeast Brazil J. Mycol. Med. 2017 27 57 64 10.1016/j.mycmed.2016.08.009 27663203 27. de Albuquerque Maranhão F.C. Oliveira-Júnior J.B. dos Santos Araújo M.A. Silva D.M.W. Mycoses in northeastern Brazil: Epidemiology and prevalence of fungal species in 8 years of retrospective analysis in Alagoas Braz. J. Microbiol. 2019 50 969 978 10.1007/s42770-019-00096-0 31140098 28. Araya S. Tesfaye B. Fente D. Epidemiology of dermatophyte and non-dermatophyte fungi infection in Ethiopia Clin. Cosmet. Investig. Dermatol. 2020 13 291 297 10.2147/CCID.S246183 29. Bitew A. Dermatophytosis: Prevalence of Dermatophytes and Non-Dermatophyte Fungi from Patients Attending Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia Dermatol. Res. Pract. 2018 2018 1 6 10.1155/2018/8164757 30402089 30. Coulibaly O. L’Ollivier C. Piarroux R. Ranque S. Epidemiology of human dermatophytoses in Africa Med. Mycol. 2017 56 145 161 10.1093/mmy/myx048 31. Das S. De A. Saha R. Sharma N. Khemka M. Singh S. Hesanoor Reja A. Kumar P. The current Indian epidemic of dermatophytosis: A study on causative agents and sensitivity patterns Indian J. Dermatol. 2020 65 118 122 32180597 32. Kalita J. Sharma A. Bhardwaj A. Nag V. Dermatophytoses and spectrum of dermatophytes in patients attending a teaching hospital in Western Rajasthan, India J. Fam. Med. Prim. Care 2019 8 1418 1421 33. Thakur R. Epidemiology of cortico-steroid-modified tinea: Study of 100 cases in a rural tertiary care teaching hospital of Western Uttar Pradesh, India J. Dermatology Cosmetol. 2018 2 1 10.15406/jdc.2018.02.00087 34. Lanternier F. Pathan S. Vincent Q.B. Liu L. Cypowyj S. Prando C. Taibi L. Ammar-khodja A. Stambouli O.B. Guellil B. Deep Dermatophytosis and Inherited CARD9 Deficiency N. Engl. J. Med. 2013 369 1704 1714 10.1056/NEJMoa1208487 24131138 35. Bongomin F. Gago S. Oladele R.O. Denning D.W. Global and multi-national prevalence of fungal diseases—Estimate precision J. Fungi 2017 3 57 10.3390/jof3040057 36. García-Romero M.T. Arenas R. New insights into genes, immunity, and the occurrence of dermatophytosis J. Investig. Dermatol. 2015 135 655 657 10.1038/jid.2014.498 25666672 37. Warycha M.A. Leger M. Tzu J. Kamino H. Stein J. Deep dermatophytosis caused by Trichophyton rubrum Dermatol. Online J. 2011 17 21 22031647 38. Costa J.E.F. Neves R.P. Delgado M.M. Lima-Neto R.G. Morais V.M.S. Coêlho M.R.C.D. Dermatophytosis in patients with human immunodeficiency virus infection: Clinical aspects and etiologic agents Acta Trop. 2015 150 111 115 10.1016/j.actatropica.2015.07.012 26200786 39. Kershenovich R. Sherman S. Reiter O. Huss S.R. Didkovsky E. Mimouni D. Hodak E. Segal R. A Unique Clinicopathological Manifestation of Fungal Infection: A Case Series of Deep Dermatophytosis in Immunosuppressed Patients Am. J. Clin. Dermatol. 2017 18 697 704 10.1007/s40257-017-0276-y 28389891 40. Kim S.H. Jo I.H. Kang J. Joo S.Y. Choi J.H. Dermatophyte abscesses caused by Trichophyton rubrum in a patient without pre-existing superficial dermatophytosis: A case report BMC Infect. Dis. 2016 16 298 10.1186/s12879-016-1631-y 27317023 41. Su H. Li L. Cheng B. Zhu J. Zhang Q. Xu J. Zhu M. Trichophyton rubrum Infection Characterized by Majocchi’s Granuloma and Deeper Dermatophytosis: Case Report and Review of Published Literature Mycopathologia 2017 182 549 554 10.1007/s11046-016-0099-z 28004227 42. Dai Y. Xia X. Shen H. Multiple abscesses in the lower extremities caused by Trichophyton rubrum BMC Infect. Dis. 2019 19 271 10.1186/s12879-019-3897-3 30894136 43. Seo J.-K. Jeong K.-H. Shin M.K. Choi J.S. Lee M.-H. Dermal Infection with Trichophyton rubrum in an Immunocompetent Patient Ann. Dermatol. 2019 31 S32 10.5021/ad.2019.31.S.S32 44. Zhang M. Jiang L. Li F. Xu Y. Lv S. Wang B. Simultaneous dermatophytosis and keratomycosis caused by Trichophyton interdigitale infection: A case report and literature review BMC Infect. Dis. 2019 19 983 10.1186/s12879-019-4612-0 31752715 45. Rouzaud C. Hay R. Chosidow O. Dupin N. Puel A. Lortholary O. Lanternier F. Severe dermatophytosis and acquired or innate immunodeficiency: A review J. Fungi 2016 2 4 10.3390/jof2010004 46. Zhong X. Chen B. Yang L. Yang Z. Molecular and physiological roles of the adaptor protein CARD9 in immunity review-article Cell Death Dis. 2018 9 1 11 10.1038/s41419-017-0084-6 29298988 47. Vaezi A. Mardani M. Fakhim H. Yaghoobi M.H. Abtahian Z. Nasri E. Geramishoar M. Khodavaisy S. Meis J.F. Badali H. Severe disseminated phaeohyphomycosis in a patient with inherited card9 deficiency Arch. Clin. Infect. Dis. 2018 13 13 10.5812/archcid.84006 48. Begum J. Mir N.A. Lingaraju M.C. Buyamayum B. Dev K. Recent advances in the diagnosis of dermatophytosis J. Basic Microbiol. 2020 60 293 303 10.1002/jobm.201900675 32003043 49. Ates A. Ozcan K. Ilkit M. Diagnostic value of morphological, physiological and biochemical tests in distinguishing Trichophyton rubrum from Trichophyton mentagrophytes complex Med. Mycol. 2008 46 811 822 10.1080/13693780802108458 18608891 50. Nenoff P. Krüger C. Schaller J. Ginter-Hanselmayer G. Schulte-Beerbühl R. Tietz H.J. Mycology—An update Part 2: Dermatomycoses: Clinical picture and diagnostics JDDG J. Ger. Soc. Dermatology 2014 12 749 777 10.1111/ddg.12420 25176455 51. Lipner S.R. Scher R.K. Onychomycosis: Clinical overview and diagnosis J. Am. Acad. Dermatol. 2019 80 835 851 10.1016/j.jaad.2018.03.062 29959961 52. Baudraz-Rosselet F. Ruffieux C. Lurati M. Bontems O. Monod M. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents Dermatology 2010 220 164 168 10.1159/000277762 20110639 53. Verrier J. Monod M. Diagnosis of Dermatophytosis Using Molecular Biology Mycopathologia 2017 182 193 202 10.1007/s11046-016-0038-z 27480761 54. Pihet M. Govic Y. Le Reappraisal of conventional diagnosis for dermatophytes Mycopathologia 2017 182 169 180 10.1007/s11046-016-0071-y 27718160 55. Rothmund G. Sattler E.C. Kaestle R. Fischer C. Haas C.J. Starz H. Welzel J. Confocal laser scanning microscopy as a new valuable tool in the diagnosis of onychomycosis—Comparison of six diagnostic methods Mycoses 2013 56 47 55 10.1111/j.1439-0507.2012.02198.x 22524550 56. Luk N.M. Hui M. Cheng T.S. Tang L.S. Ho K.M. Evaluation of PCR for the diagnosis of dermatophytes in nail specimens from patients with suspected onychomycosis Clin. Exp. Dermatol. 2012 37 230 234 10.1111/j.1365-2230.2011.04258.x 22300052 57. Álvarez-Mosquera I. Hernáez S. Sánchez J. Suárez M.D. Cisterna R. Diagnosis of Superficial Mycoses by a Rapid and Effective PCR Method from Samples of Scales, Nails and Hair Mycopathologia 2018 183 777 783 10.1007/s11046-018-0290-5 30094709 58. Piri F. Zarei Mahmoudabadi A. Ronagh A. Ahmadi B. Makimura K. Rezaei-Matehkolaei A. Assessment of a pan-dermatophyte nested-PCR compared with conventional methods for direct detection and identification of dermatophytosis agents in animals Mycoses 2018 61 837 844 10.1111/myc.12821 29944743 59. Hwee Koo S. Leng Teoh Y. Liang Koh W. Ochi H. Kye Tan S. Miao Fang Sim D. Jiang B. Ling Tan A. Yen Tan T. Ping Regina Lim S. Development and validation of a real-time multiplex PCR assay for the detection of dermatophytes and Fusarium spp. J. Med. Microbiol. 2019 68 1641 1648 10.1099/jmm.0.001082 31526456 60. Dhib I. Fathallah A. Yaacoub A. Hadj Slama F. Said M.B. Zemni R. Multiplex PCR assay for the detection of common dermatophyte nail infections Mycoses 2014 57 19 26 10.1111/myc.12096 23734576 61. Lubis N.Z. Muis K. Nasution L.H. Polymerase chain reaction-restriction fragment length polymorphism as a confirmatory test for onychomycosis Open Access Maced. J. Med. Sci. 2018 6 280 283 10.3889/oamjms.2018.098 29531588 62. Mohammadi R. Abastabar M. Mirhendi H. Badali H. Shadzi S. Chadeganipour M. Pourfathi P. Jalalizand N. Haghani I. Use of restriction fragment length polymorphism to rapidly identify dermatophyte species related to dermatophytosis Jundishapur J. Microbiol. 2015 8 4 9 10.5812/jjm.8(5)2015.17296 63. Beifuss B. Bezold G. Gottlöber P. Borelli C. Wagener J. Schaller M. Korting H.C. Direct detection of five common dermatophyte species in clinical samples using a rapid and sensitive 24-h PCR-ELISA technique open to protocol transfer Mycoses 2011 54 137 145 10.1111/j.1439-0507.2009.01771.x 19793206 64. Nenoff P. Verma S.B. Vasani R. Burmester A. Hipler U.C. Wittig F. Krüger C. Nenoff K. Wiegand C. Saraswat A. The current Indian epidemic of superficial dermatophytosis due to Trichophyton mentagrophytes—A molecular study Mycoses 2019 336 356 10.1111/myc.12878 30561859 65. Jacobson L.S. McIntyre L. Mykusz J. Assessment of real-time PCR cycle threshold values in Microsporum canis culture-positive and culture-negative cats in an animal shelter: A field study J. Feline Med. Surg. 2018 20 108 113 10.1177/1098612X17706270 28425361 66. Gong J. Ran M. Wang X. Wan Z. Li R. Development and Evaluation of a Novel Real-Time PCR for Pan-Dermatophyte Detection in Nail Specimens Mycopathologia 2016 181 51 57 10.1007/s11046-015-9915-0 26412381 67. Sherman S. Goshen M. Treigerman O. Ben-Zion K. Carp M.-J. Maisler N. Ehrenreich I.B. Kimchi A. Lifshitz S. Smollan G. Evaluation of multiplex real-time PCR for identifying dermatophytes in clinical samples—A multicentre study Mycoses 2017 61 119 126 10.1111/myc.12713 29024067 68. Hayette M.P. Seidel L. Adjetey C. Darfouf R. Wéry M. Boreux R. Sacheli R. Melin P. Arrese J. Clinical evaluation of the DermaGeniusR Nail real-time PCR assay for the detection of dermatophytes and Candida albicans in nails Med. Mycol. 2019 57 277 283 10.1093/mmy/myy020 29762721 69. De Respinis S. Monnin V. Girard V. Welker M. Arsac M. Cellière B. Durand G. Bosshard P.P. Farina C. Passera M. Matrix-assisted laser desorption ionization-time of flight (MALDITOF) mass spectrometry using the Vitek MS system for rapid and accurate identification of dermatophytes on solid cultures J. Clin. Microbiol. 2014 52 4286 4292 10.1128/JCM.02199-14 25297329 70. Theel E.S. Hall L. Mandrekar J. Wengenack N.L. Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry J. Clin. Microbiol. 2011 49 4067 4071 10.1128/JCM.01280-11 21956979 71. Packeu A. De Bel A. L’Ollivier C. Ranque S. Detandt M. Hendrickx M. Fast and accurate identification of dermatophytes by matrix-assisted laser desorption ionization-time of flight mass spectrometry: Validation in the clinical laboratory J. Clin. Microbiol. 2014 52 3440 3443 10.1128/JCM.01428-14 25031434 72. L’Ollivier C. Cassagne C. Normand A.C. Bouchara J.P. Contet-Audonneau N. Hendrickx M. Fourquet P. Coulibaly O. Piarroux R. Ranque S. A MALDI-TOF MS procedure for clinical dermatophyte species identification in the routine laboratory Med. Mycol. 2013 51 713 720 10.3109/13693786.2013.781691 23611419 73. Nenoff P. Erhard M. Simon J.C. Muylowa G.K. Herrmann J. Rataj W. Gräser Y. MALDI-TOF mass spectrometry—A rapid method for the identification of dermatophyte species Med. Mycol. 2013 51 17 24 10.3109/13693786.2012.685186 22574631 74. De Respinis S. Tonolla M. Pranghofer S. Petrini L. Petrini O. Bosshard P.P. Identification of dermatophytes by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Med. Mycol. 2013 51 514 521 10.3109/13693786.2012.746476 23228046 75. Erhard M. Hipler U.C. Burmester A. Brakhage A.A. Wöstemeyer J. Identification of dermatophyte species causing onychomycosis and tinea pedis by MALDI-TOF mass spectrometry Exp. Dermatol. 2008 17 356 361 10.1111/j.1600-0625.2007.00649.x 17979969 76. Alshawa K. Beretti J.L. Lacroix C. Feuilhade M. Dauphin B. Quesne G. Hassouni N. Nassif X. Bougnoux M.E. Successful identification of clinical dermatophyte and Neoscytalidium species by matrix-assisted laser desorption ionization-time of flight mass spectrometry J. Clin. Microbiol. 2012 50 2277 2281 10.1128/JCM.06634-11 22535981 77. Calderaro A. Motta F. Montecchini S. Gorrini C. Piccolo G. Piergianni M. Buttrini M. Medici M.C. Arcangeletti M.C. Chezzi C. Identification of Dermatophyte Species after implementation of the in-house MALDI-TOF MS database Int. J. Mol. Sci. 2014 15 16012 16024 10.3390/ijms150916012 25216335 78. Karabıçak N. Karatuna O. İlkit M. Akyar I. Evaluation of the Bruker Matrix-Assisted Laser Desorption–Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) System for the Identification of Clinically Important Dermatophyte Species Mycopathologia 2015 180 165 171 10.1007/s11046-015-9898-x 25971934 79. L’Ollivier C. Ranque S. MALDI-TOF-Based Dermatophyte Identification Mycopathologia 2017 182 183 192 10.1007/s11046-016-0080-x 27734185 80. Murray P.R. What Is new in clinical microbiologymicrobial identification by MALDI-TOF mass spectrometry: A paper from the 2011 William Beaumont Hospital symposium on molecular pathology J. Mol. Diagn. 2012 14 419 423 10.1016/j.jmoldx.2012.03.007 22795961 81. Fagerquist C.K. Garbus B.R. Miller W.G. Williams K.E. Yee E. Bates A.H. Boyle S. Harden L.A. Cooley M.B. Mandrell R.E. Rapid identification of protein biomarkers of escherichia coli O157:H7 by matrix-assisted laser desorption Lonization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics Anal. Chem. 2010 82 2717 2725 10.1021/ac902455d 20232878 82. Sacheli R. Henri A.S. Seidel L. Ernst M. Darfouf R. Adjetey C. Schyns M. Marechal L. Meex C. Arrese J. Evaluation of the new Id-Fungi plates from Conidia for MALDI-TOF MS identification of filamentous fungi and comparison with conventional methods as identification tool for dermatophytes from nails, hair and skin samples Mycoses 2020 63 1115 1127 10.1111/myc.13156 32757444 83. Sanguinetti M. Posteraro B. Identification of molds by matrix-assisted laser desorption ionization-time of flight mass spectrometry J. Clin. Microbiol. 2017 55 369 379 10.1128/JCM.01640-16 27807151 84. Santos C. Paterson R.R.M. Venâncio A. Lima N. Filamentous fungal characterizations by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry J. Appl. Microbiol. 2010 108 375 385 10.1111/j.1365-2672.2009.04448.x 19659699 85. Robert R. Pihet M. Conventional methods for the diagnosis of dermatophytosis Mycopathologia 2008 166 295 306 10.1007/s11046-008-9106-3 18478359 86. Hay R. Literature review J. Eur. Acad. Dermatol. Venereol. 2005 19 1 7 10.1111/j.1468-3083.2005.01288.x 87. de Hoog G.S. Dukik K. Monod M. Packeu A. Stubbe D. Hendrickx M. Kupsch C. Stielow J.B. Freeke J. Göker M. Toward a Novel Multilocus Phylogenetic Taxonomy for the Dermatophytes Mycopathologia 2017 182 5 31 10.1007/s11046-016-0073-9 27783317 88. Sanguinetti M. Posteraro B. MALDI-TOF Mass Spectrometry: Any Use for Aspergilli? Mycopathologia 2014 178 417 426 10.1007/s11046-014-9757-1 25001870 89. Posteraro B. De Carolis E. Vella A. Sanguinetti M. MALDI-TOF mass spectrometry in the clinical mycology laboratory: Identification of fungi and beyond Expert Rev. Proteom. 2013 10 151 164 10.1586/epr.13.8 90. Schulthess B. Ledermann R. Mouttet F. Zbinden A. Bloemberg G.V. Böttger E.C. Hombach M. Use of the Bruker MALDI Biotyper for identification of molds in the clinical mycology laboratory J. Clin. Microbiol. 2014 52 2797 2803 10.1128/JCM.00049-14 24850347 91. Lau A.F. Drake S.K. Calhoun L.B. Henderson C.M. Zelazny A.M. Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-Time of flight mass spectrometry J. Clin. Microbiol. 2013 51 828 834 10.1128/JCM.02852-12 23269728 92. Pennanec X. Dufour A. Haras D. Réhel K. A quick and easy method to identify bacteria by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry Rapid Commun. Mass Spectrom. 2010 24 384 392 10.1002/rcm.4404 20049880 93. Patel R. A moldy application of MALDI: MALDI-ToF mass spectrometry for fungal identification J. Fungi 2019 5 4 10.3390/jof5010004 94. Normand A.C. Becker P. Gabriel F. Cassagne C. Accoceberry I. Gari-Toussaint M. Hasseine L. De Geyter D. Pierard D. Surmont I. Validation of a new web application for identification of fungi by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry J. Clin. Microbiol. 2017 55 2661 2670 10.1128/JCM.00263-17 28637907 95. Hedayati M.T. Ansari S. Ahmadi B. Armaki M.T. Shokohi T. Abastabar M. Er H. Özhak B. Öğünç D. Ilkit M. Identification of clinical dermatophyte isolates obtained from Iran by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Curr. Med. Mycol. 2019 2019 22 26 96. Gupta A.K. Foley K.A. Versteeg S.G. New Antifungal Agents and New Formulations Against Dermatophytes Mycopathologia 2017 182 127 141 10.1007/s11046-016-0045-0 27502503 97. Cantelli B.A.M. Bitencourt T.A. Komoto T.T. Beleboni R.O. Marins M. Fachin A.L. Caffeic acid and licochalcone A interfere with the glyoxylate cycle of Trichophyton rubrum Biomed. Pharmacother. 2017 96 1389 1394 10.1016/j.biopha.2017.11.051 29174577 98. Komoto T.T. Bitencourt T.A. Silva G. Beleboni R.O. Marins M. Fachin A.L. Gene Expression Response of Trichophyton rubrum during Coculture on Keratinocytes Exposed to Antifungal Agents Evidence-Based Complement. Altern. Med. 2015 2015 1 7 10.1155/2015/180535 26257814 99. Bitencourt T.A. Komoto T.T. Massaroto B.G. Miranda C.E.S. Beleboni R.O. Marins M. Fachin A.L. Trans-chalcone and quercetin down-regulate fatty acid synthase gene expression and reduce ergosterol content in the human pathogenic dermatophyte Trichophyton rubrum BMC Complement. Altern. Med. 2013 13 229 10.1186/1472-6882-13-229 24044691 100. de Abreu M.H. Bitencourt T.A. Franco M.E. Moreli I.S. Cantelli B.A.M. Komoto T.T. Marins M. Fachin A.L. Expression of genes containing tandem repeat patterns involved in the fungal-host interaction and in the response to antifungals in Trichophyton rubrum Mycoses 2020 63 610 616 10.1111/myc.13088 32301521 101. Petrucelli M.F. Peronni K. Sanches P.R. Komoto T.T. Matsuda J.B. da Silva Junior W.A. Beleboni R.O. Martinez-Rossi N.M. Marins M. Fachin A.L. Dual RNA-Seq analysis of trichophyton rubrum and HaCat keratinocyte co-culture highlights important genes for fungal-host interaction Genes (Basel) 2018 9 362 10.3390/genes9070362 102. Bitencourt T.A. Macedo C. Franco M.E. Assis A.F. Komoto T.T. Stehling E.G. Beleboni R.O. Malavazi I. Marins M. Fachin A.L. Transcription profile of Trichophyton rubrum conidia grown on keratin reveals the induction of an adhesin-like protein gene with a tandem repeat pattern BMC Genom. 2016 17 249 10.1186/s12864-016-2567-8 103. Petrucelli M.F. Matsuda J.B. Peroni K. Sanches P.R. Silva W.A. Beleboni R.O. Martinez-Rossi N.M. Marins M. Fachin A.L. The transcriptional profile of Trichophyton rubrum co-cultured with human keratinocytes shows new insights about gene modulation by terbinafine Pathogens 2019 8 274 10.3390/pathogens8040274